Literature DB >> 34982245

CD44-positive cancer stem cells from oral squamous cell carcinoma exhibit reduced proliferation and stemness gene expression upon adipogenic induction.

Shankargouda Patil1, Ashraf Al-Brakati2, Nazim H Abidi3, Mazen A Almasri4, Asma Saleh Almeslet5, Vikrant R Patil6, A Thirumal Raj7, Shilpa Bhandi8.   

Abstract

We proposed to assess adipogenic differentiation and its effect on the proliferation and stemness markers in CD44 + OSCC CSCs. D44 + CSCs were sorted by magnetic sorting from the single-cell suspension of the OSCC tumor. Adipogenic differentiation was induced by an adipogenic induction medium. Lipid droplet formation was confirmed by oil red O staining. The expression of the cell surface marker was analyzed by flow cytometry. Real-time qPCR was performed to examine the gene expression activity. CD44 + OSCC CSCs can differentiate into adipocytes and adipogenesis in these cells decrease their proliferation and stemness gene expression. Adipogenic induction can make the cancer stem cells from OSCC tumors lose their stemness potential. Oral cancer, especially OSCC, is a huge burden worldwide. Similar to other stem cells, cancer stem cells can differentiate into other lineage cells. Our study shows that the proliferation and stemness gene expression in the CSCs from OSCC tumors can be thwarted by inducing them to differentiate into adipocytes, which could be advantageous to find out new clinical approaches in the treatment of cancers, like OSCC.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adipogenic differentiation; CD44; Cancer stem cells; OSCC; Stemness

Mesh:

Substances:

Year:  2022        PMID: 34982245     DOI: 10.1007/s12032-021-01617-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  7 in total

1.  Relationship between CD44high/CD133high/CD117high cancer stem cells phenotype and Cetuximab and Paclitaxel treatment response in head and neck cancer cell lines.

Authors:  Ana Livia Silva Galbiatti-Dias; Glaucia Maria Mendonça Fernandes; Marcia Maria Urbanin Castanhole-Nunes; Luiza Fernandes Hidalgo; Carlos Henrique Viesi Nascimento Filho; Rosa Sayoko Kawasaki-Oyama; Leticia Antunes Muniz Ferreira; Patricia Matos Biselli-Chicote; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  Multidrug resistance and tumor-initiating capacity of oral cancer stem cells.

Authors:  Hong-Guo Shang; Hong-Ling Yu; Xiao-Ni Ma; Xin Xu
Journal:  J BUON       Date:  2016 Mar-Apr       Impact factor: 2.533

3.  Propranolol enhanced adipogenesis instead of induction of apoptosis of hemangiomas stem cells.

Authors:  Xiaorong Ma; Tinghui Zhao; Tianxiang Ouyang; Shujia Xin; Yueting Ma; Mengling Chang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

Authors:  S Castaigne; C Chomienne; M T Daniel; P Ballerini; R Berger; P Fenaux; L Degos
Journal:  Blood       Date:  1990-11-01       Impact factor: 22.113

5.  Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies.

Authors:  Mohammed Talha Shekhani; Ashika-Sita Jayanthy; Nityanand Maddodi; Vijayasaradhi Setaluri
Journal:  Am J Stem Cells       Date:  2013-03-08

Review 6.  Stem cells in cancer initiation and progression.

Authors:  Jeevisha Bajaj; Emily Diaz; Tannishtha Reya
Journal:  J Cell Biol       Date:  2020-01-06       Impact factor: 10.539

7.  Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites.

Authors:  Christina Wefers; Tjitske Duiveman-de Boer; Refika Yigit; Petra L M Zusterzeel; Anne M van Altena; Leon F A G Massuger; I Jolanda M De Vries
Journal:  Front Immunol       Date:  2019-01-11       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.